Market research
SEQUA.BR Sequana Medical NV
BR EUR Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 48M
- P/E ratio
- Not available
- Analyst target
- 1.5
- Dividend yield
- Not available
- Beta
- -0.29
Community
Investor discussion
1 comment
Sign in to join the SEQUA.BR discussion.
5 years, 5 months ago
Sequana Medical NV is currently in a long term downtrend where the price is trading 1.0% below its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 121.6.
Sequana Medical NV's total revenue rose by 6.6% to $595K since the same quarter in the previous year.
Its net income has dropped by 24.5% to $-10M since the same quarter in the previous year.
Finally, its free cash flow fell by 13.1% to $-4M since the same quarter in the previous year.
Based on the above factors, Sequana Medical NV gets an overall score of 2/5.